UGIC Biomedical Science Project: BCG Tuberculosis Vaccine Report

This report provides an overview of the BCG (Bacillus Calmette-Guérin) tuberculosis vaccine. It begins with an introduction to tuberculosis, its causes, symptoms, and treatment. The main body details the vaccine's composition, dosage, and potential side effects. It also specifies the target population for the vaccine, including babies born in high-risk areas and individuals with close contact to TB patients. The report concludes by summarizing the vaccine's effectiveness in triggering the immune system and protecting against severe forms of TB, while acknowledging its limited efficacy against pulmonary TB. The report is supported by references to relevant research and publications. This report is part of a UGIC Biomedical Science project.